Pediatric Brain Tumors Shrink from Epigenome Targeted Therapy

Traditional cancer treatments such as chemotherapy and radiation have always been a trade-off: survival now, more cancer later. While many of these treatment regimens are effective at stopping various cancer’s progression, the genomic damage that they leave in their wake can often lead to new tumors years later. This is extremely problematic for children—whose bodies are still growing and are much more susceptible to the detrimental aspects of the drugs. This is particularly true for children with brain cancer, and researchers are working hard to find treatments that reduce side effects while remaining effective.

https://www.genengnews.com